Gerhard Held

机构：Westpfalz Klinikum · ORCID：0000-0002-2932-3140

发表论文 311 篇 · 总被引 9904 次 · h-index 50

代表论文

• Genetic Characterization of Primary Mediastinal B-Cell Lymphoma: Pathogenesis and Patient Outcomes (2023 · Journal of Clinical Oncology · 被引 39)
• SPARC-positive macrophages are the superior prognostic factor in the microenvironment of diffuse large B-cell lymphoma and independent of MYC rearrangement and double-/triple-hit status (2021 · Annals of Oncology · 被引 29)
• Radiation and Dose-densification of R-CHOP in Primary Mediastinal B-cell Lymphoma: Subgroup Analysis of the UNFOLDER Trial (2023 · HemaSphere · 被引 17)
• Radiation and Dose-densification of R-CHOP in Aggressive B-cell Lymphoma With Intermediate Prognosis: The UNFOLDER Study (2023 · HemaSphere · 被引 17)
• B-cell receptor reactivity against Rothia mucilaginosa in nodular lymphocyte-predominant Hodgkin lymphoma (2023 · Haematologica · 被引 17)
• Single Versus Double Induction with "7+3" Containing 60 Versus 90 Mg Daunorubicin for Newly Diagnosed AML: Results from the Randomized Controlled SAL Dauno-Double Trial (2022 · Blood · 被引 17)